TM6SF2 and metabolic dysfunction-associated steatohepatitis: Fifty-two per cent (50/97) of metabolites associated with NASH-fibrosis variants were also associated with liver fat variants, again the majority (86%, 43/50) were PC species due to similarity between GCKR and TM6SF2 metabolite associations (Supplementary Material, Table S3).